- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04440709
Brain/Neural Hand Exoskeleton Control for Restoration of Bimanual Tasks
June 18, 2020 updated by: University Hospital Tuebingen
Restoration of Bimanual Activities of Daily Living Using a Brain/Neural Hand Exoskeleton (B/NHE) in Hand Paralysis
This study investigates whether spinal cord injury and stroke survivors (n=10) are able to operate a brain/neural hand exoskeleton (B/NHE) based on electroencephalography (EEG) and electrooculography (EOG) for restoration of bimanual activities of daily living (ADLs).
To assess bimanual ADLs, the Berlin Bimanual Task Assessment (BEBITA) will be applied.
Improvements in BEBITA will be evaluated with and without B/NHE use.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Berlin, Germany, 10117
- Recruiting
- Charité - University Medicine Berlin
-
Contact:
- Surjo R Soekadar, MD
- Phone Number: +49 30 450 528 153
- Email: surjo.soekadar@charite.de
-
-
BW
-
Tuebingen, BW, Germany, 72076
- Recruiting
- University Hospital Tuebingen
-
Contact:
- Surjo R. Soekadar, MD
- Phone Number: +49-163-1644889
- Email: surjo.soekadar@uni-tuebingen.de
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 68 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria (Stroke):
- single ischemic or hemorrhagic insult with subcortical lesion (medullary canal, internal capsula, pedunculi cerebri)
- interval since stroke at least 6 months
- substantial motor deficit with:
- Medical Research Council (MRC) -score of less than 2 out of 6 possible points (0=no activity; 1=visible contraction without motor effect; 2=movements with elimination of gravity; 3=movements against gravity; 4=movements against weak resistance; 5=normal force)
- Fugl-Meyer Test (upper extremity) of less than 31 points, "no to little mobility"
Inclusion Criteria (Spinal Cord Injury):
- cervical spinal cord injury, height C5-C6
- interval after spinal cord injury at least 6 months
- substantial motor deficit with American Spinal Cord Association (ASIA) -Classification B or C (A=no muscle function/sensitivity below the spinal cord injury; B=no muscle function, limited sensitivity present; C=low non-relevant muscle function, sensitivity present; D=functionally relevant muscle functions present; E=fully preserved or restored functions)
Exclusion Criteria (Stroke and Spinal Cord Injury):
- Alcohol or drug problem (regular consumption of more than 2 alcoholic beverages per day, or taking illegal drugs)
- currently undergoing neurological or psychiatric treatment based on a secondary diagnosis
- Severe and uncontrollable medical problems:
- Non-adjusted malignant high blood pressure, World Health Organization (WHO) Hypertension Grade II
- non-adjustable diabetes mellitus, HbA1c > 58 mmol/mol
- renal failure, from KDIGO glomerular filtration rate (GFR) category G3b (moderate to severe impairment)
- Liver failure, Child-Pugh stages B and C
- Heart failure New York Heart Association (NYHA) grade III-IV
- malignant tumor disease
- severe arrhythmia in need of treatment
- severe oedemas
- severe arthritis
- serious cognitive impairment (minimum status below 23 points)
- Severe spasticity (Ashworth grade ≥ 4)
- Pregnancy
- Bilateral motor deficit (in stroke patients)
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Brain/neural hand exoskeleton (B/NHE)
|
The brain/neural hand exoskeleton restores hand motor function by translating user's intention into grasping motions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Change in Berlin Bimanual Task Assessment (BEBITA) score
Time Frame: Hand function will be assessed twice on the same day. Once before the hand exoskeleton is applied (absence of the assistive device) and once after the brain-controlled hand exoskeleton was attached to the patients' hand and arm.
|
Hand function will be assessed twice on the same day. Once before the hand exoskeleton is applied (absence of the assistive device) and once after the brain-controlled hand exoskeleton was attached to the patients' hand and arm.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
June 1, 2020
Primary Completion (Anticipated)
July 1, 2020
Study Completion (Anticipated)
October 1, 2020
Study Registration Dates
First Submitted
June 18, 2020
First Submitted That Met QC Criteria
June 18, 2020
First Posted (Actual)
June 22, 2020
Study Record Updates
Last Update Posted (Actual)
June 22, 2020
Last Update Submitted That Met QC Criteria
June 18, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- NEU007/1
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stroke
-
National Assembly ClinicBayero University Kano, NigeriaRecruitingStroke | Stroke Hemorrhagic | Stroke Ischemic | Hemiparesis After StrokeNigeria
-
University of PittsburghRecruitingHemorrhagic Stroke | Embolic Stroke of Undetermined Source | Ischemic Stroke, Cryptogenic | Recurrent Ischemic Stroke | Ischemic Stroke, EmbolicUnited States
-
Mahidol UniversityNot yet recruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke SurvivorsThailand
-
Mahidol UniversityRecruitingIschemic Stroke | Hemorrhagic Stroke | Subacute Stroke | Chronic Stroke PatientThailand
-
University Hospital, GhentRecruitingStroke | Stroke, Ischemic | Stroke, Acute | Stroke Sequelae | Stroke HemorrhagicBelgium
-
Moleac Pte Ltd.Not yet recruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke, Cardiovascular | Strokes Thrombotic | Stroke, Embolic | Stroke, Cryptogenic
-
Samsung Medical CenterCompletedChronic Stroke | Subacute Stroke | ExoskeletonSouth Korea
-
University of Illinois at ChicagoRecruitingStroke, Ischemic | Stroke Hemorrhagic | Stroke, CerebrovascularUnited States
-
IRCCS San Camillo, Venezia, ItalyRecruitingStroke | Stroke, Ischemic | Stroke Sequelae | Stroke HemorrhagicItaly
-
Fondazione Don Carlo Gnocchi OnlusScuola Superiore Sant'Anna di Pisa; Fondazione Policlinico Universitario Campus...Not yet recruitingStroke | Stroke Hemorrhagic | Upper Limb Rehabilitation | Stroke IschemicItaly
Clinical Trials on Brain/neural hand exoskeleton (B/NHE)
-
Russian Academy of Medical SciencesPirogov Russian National Research Medical UniversityCompletedPoststroke/CVA ParesisRussian Federation
-
Children's Oncology GroupNational Cancer Institute (NCI)RecruitingChildhood MedulloblastomaUnited States, Canada